Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

289

HTML

2119

Figures (1-5)

117

Sum=2525

Apr 15, 2003 (publication date) through Apr 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Apr 15, 2003; 9(4): 688-691
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.688

Full Size Figure Download Figure

Figure 4 Transient expression of EGFP. A. EGFP expressing in HepG2; B. EGFP do not express in Hela cells.

Citation: Lu SY, Sui YF, Li ZS, Pan CE, Ye J, Wang WY. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma. World J Gastroenterol 2003; 9(4): 688-691
URL: https://www.wjgnet.com/1007-9327/full/v9/i4/688.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i4.688